Top Story

Integrase inhibitors favorable as initial HIV therapy

October 20, 2014

PHILADELPHIA — Joel Gallant, MD, MPH, of the Southwest Care Center in Santa Fe, N.M., and outgoing chair of the HIVMA, gives an overview of his talk at IDWeek, “What’s Hot in HIV.”

Gallant discussed recent studies about starting ART with integrase inhibitors, the approval of cobicistat (Tybost, Gilead Sciences) as a standalone agent, upcoming coformulations of protease inhibitors and cobicistat and the development of the prodrug tenofovir alafemanide. In addition, he discussed the continuing data on PrEP, the important PARTNER study of serodiscordant couples, and progress and setbacks in the search for a cure.

10 economic consequences of the Ebola crisis

October 20, 2014
The 2014 Ebola outbreak is the deadliest in recorded history, with 8,997 cases and 4,493 deaths reported by WHO as of Oct. 16. Recent infection of health care workers in…
Worth Building

Follow a checklist to help decide what to do with estate life insurance

October 20, 2014
Before recent changes in estate laws, it was common for attorneys, financial planners and insurance agents to recommend purchasing life insurance — commonly called…
Meeting News Coverage

Efficacy similar between two single-tablet ART regimens in females

October 20, 2014
PHILADELPHIA — There was no difference in efficacy or adverse events between two single-tablet regimens in treatment-naive women with HIV at week 96, according to…
More News Headlines »
Editorial
figure

Managing the threat of untreatable gonorrhea

Infectious Disease News, September 2014
Stephanie Chisholm; Gwenda Hughes, BA(Hons), PhD, FFPH; Kevin A. Fenton, MD, PhD, FFPH
Gonorrhea is a sexually transmitted infection that can lead to serious reproductive tract morbidity if untreated and…
More »
Blog

Updates to adult immunization schedule

January 30, 2013
Each year in January, the CDC publishes an adult immunization schedule, updating information relating to the vaccines…
More »
Meeting News Coverage Video
figure

Integrase inhibitors favorable as initial HIV therapy

October 20, 2014
PHILADELPHIA — Joel Gallant, MD, MPH, of the Southwest Care Center in Santa Fe, N.M., and outgoing chair of the…
More »